Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Atkins

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Leukemia & Lymphoma|July 9, 2008
Treatment of relapsed and refractory myelomaDonna E Reece, Heather A Leitch, Harold Atkins, et al.
Annals of Surgery|October 31, 2012
Surgical stress promotes the development of cancer metastases by a coagulation-dependent mechanism involving natural killer cells in a murine modelRashmi Seth, Lee-Hwa Tai, Theresa Falls, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Identification of genetically modified Maraba virus as an oncolytic rhabdovirusJan Brun, Dan McManus, Charles Lefebvre, et al.
Regenerative Medicine|November 14, 2015
Bringing regenerative medicines to the clinic: the future for regulation and reimbursementTania Bubela, Christopher McCabe, Peter Archibald, et al.
Leukemia & Lymphoma|June 11, 2014
A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemiaAdam Bryant, Dawn Sheppard, Mitchell Sabloff, et al.
Trials|March 26, 2021
Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview studyGisell Castillo, Manoj Lalu, Sarah Asad, et al.
The EMBO Journal|December 24, 2010
Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineagesCarmen G Palii, Carolina Perez-Iratxeta, Zizhen Yao, et al.
Systematic Reviews|January 18, 2023
Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocolManoj M Lalu, Natasha Kekre, Joshua Montroy, et al.
Annals of Clinical and Translational Neurology|December 31, 2024
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantationBenjamin Beland, Jan Storek, Liam Quartermain, et al.
BMJ Open|August 13, 2021
Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapyMackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|July 9, 2008
Treatment of relapsed and refractory myelomaDonna E Reece, Heather A Leitch, Harold Atkins, et al.
Annals of Surgery|October 31, 2012
Surgical stress promotes the development of cancer metastases by a coagulation-dependent mechanism involving natural killer cells in a murine modelRashmi Seth, Lee-Hwa Tai, Theresa Falls, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Identification of genetically modified Maraba virus as an oncolytic rhabdovirusJan Brun, Dan McManus, Charles Lefebvre, et al.
Regenerative Medicine|November 14, 2015
Bringing regenerative medicines to the clinic: the future for regulation and reimbursementTania Bubela, Christopher McCabe, Peter Archibald, et al.
Leukemia & Lymphoma|June 11, 2014
A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemiaAdam Bryant, Dawn Sheppard, Mitchell Sabloff, et al.
Trials|March 26, 2021
Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview studyGisell Castillo, Manoj Lalu, Sarah Asad, et al.
The EMBO Journal|December 24, 2010
Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineagesCarmen G Palii, Carolina Perez-Iratxeta, Zizhen Yao, et al.
Systematic Reviews|January 18, 2023
Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocolManoj M Lalu, Natasha Kekre, Joshua Montroy, et al.
Annals of Clinical and Translational Neurology|December 31, 2024
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantationBenjamin Beland, Jan Storek, Liam Quartermain, et al.
BMJ Open|August 13, 2021
Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapyMackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, et al.
Pageof 8